Superbugs and Superdrugs
Time:March 25-26, 2015
Venue:Holiday Inn Regents Park Carburton Street London W1W 5EE England
Organizer:SMi Group
Antibiotics have been one of the most transformational discoveries in medicine saving millions of lives around the world. The rise of resistance poses an unprecedented threat to public health rekindling a drive for new, effective and safe drugs to beat the superbugs, combined with efforts to raise awareness around the use of antimicrobials.
This conference takes a holistic look at the issues and aims to equip delegates to take on the challenges of conserving the effectiveness of existing antibacterial drugs, developing new ones and tackling biosecuiry and Ebola threats. Bringing in voices from pharma, academia, government, regulatory perspectives, consultants and funding bodies this conference is the ideal meeting place to share the latest updates, case studies and strategies to seize the opportunities ahead and usher in the next generation of superdrugs.
benefits of attending
• Receive the latest updates and case studies on preclinical and clinical developments
• Scan horizons on anti-microbial resistance and understand initiatives to control antimicrobial use
• Look at alternative approaches including phage and peptide and approaches
• Explore the latest updates in funding and reimbursement
• Review the current status of antimicrobial resistance and the threats and targets landscape
• Understand the potential of rapid point of care diagnostics
who should attend
Abingworth Management Ltd; Acidophil LLC; ADMISSIONS; Anacor Pharmaceuticals Inc; Astellas Pharma Europe; Basilea Pharmaceutica Ltd; Biomedical Advanced Research and Development Authority; Biopharm Insight; Brandenburg Antiinfektiva GmbH and Forschungszentrum Borstel ; Cubist Pharmaceuticals; D S T L Chemical And Biological Sciences; Da Volterra; Debiopharm SA; Euprotec; European Commision; F Hoffmann -La Roche Inc; F. Hoffmann-La Roche; Ferrer Internacional; Genentech Inc; Grifols America Inc; GSK; Idenix Laboratories; Janssen Pharmaceuticlas Limited; Johnson and Johnson Pharmaceutical Research and Development; Kings College University; KWS BioTest Ltd; MedImmune; MHRA; NDA Group; Nosopharm; Office for Health Economics; PharmaConsulting; Phico Therapeutics; Polyphor Ltd; Procarta Biosystems Ltd.; Quintiles Ltd; Roche Consumer Health; Sanofi-Aventis; SBC; SeaLife Pharma GmbH; Selcia Ltd; St George's Hospital Medical School; Summit; The Wellcome Trust; Thomson Reuters; Tiber Creek Partners; TranScrip Partners; University of North Texas Health Science Center; UNTHSC, PreClinical Services; Valoralia;
Venue
Holiday Inn Regents Park
Choose the well-connected Holiday Inn London-Regent's Park hotel, with a superb central London location and speedy transport links. Holiday Inn London-Regent's Park is in a leafy and cosmopolitan area of central London, a 10-minute walk from bustling Oxford Street. Leave your car in our NCP managed underground car park, and explore London by Tube. Great Portland Street Tube station is 25 metres from the hotel, from where you can reach the City and Canary Wharf in 30 minutes, and London Heathrow Airport in 45 minutes. Wireless Internet is available throughout the hotel, and you can invite up to 300 people to events at the Academy Conference Centre, with an IT technician and break-out zones. Holiday Inn London-Regent's Park is a 10-minute walk from Santander's offices and businesses in the BT Tower. Stroll 5 minutes to Regent's Park, where you'll find London Zoo and pretty Primrose Hill. We're a 10-minute walk from Bond Street boutiques and 20 minutes from Buckingham Palace and cruises on the River Thames. Ask our Concierge to plan your day out and book West End theatre tickets. Room Service is available 24 hours at Holiday Inn London-Regent's Park, or dine in the vibrant Junction Restaurant. Our Junction Bar has a menu of light bites, and a hot breakfast buffet is served daily.
Pharma Sources Insight July 2025
